Related Experiment Video
Updated: Jun 21, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls
Robin L Carhart-Harris1, David J Nutt, Marcus R Munafo
1Psychopharmacology Unit, University of Bristol, Bristol, UK. r.carhart-harris@bris.ac.uk
Introduction:
This study sought to test the association between 3,4-methylenedioxymethamphetamine use, serotonergic function and sleep.
Materials And Methods:
Ambulatory polysomnography was used to measure three nights sleep in 12 ecstasy users and 12 controls after screening (no intervention), a tryptophan-free amino acid mixture (acute tryptophan depletion (ATD)) and a tryptophan-supplemented control mixture.
Results:
ATD significantly decreased rapid eye movement (REM) sleep onset latency, increased the amount of REM sleep and increased the amount of stage 2 sleep in the first 3 h of sleep. There was no difference between ecstasy users' and controls' sleep on the screening night or after ATD.
Discussion:
These findings imply that the ecstasy users had not suffered significant serotonergic damage as indexed by sleep.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
CNS Stimulants: Psychedelic Agents
REM Sleep Behavior Disorder
RBD is significantly associated with...
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...